Evidence map›Paper›PMID 37175012›Full record

ArticleDiagnostics (Basel, Switzerland)2023

A Novel Hybrid Runge Kutta Optimizer with Support Vector Machine on Gene Expression Data for Cancer Classification.

Essam H Houssein, Hager N Hassan, Nagwan Abdel Samee, Mona M Jamjoom

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Essam H HousseinFaculty of Computers and Information, Minia University, Minia 61519, Egypt.ORCID 0000-0002-8127-7233
Hager N HassanFaculty of Computers and Information, Minia University, Minia 61519, Egypt.
Nagwan Abdel SameeDepartment of Information Technology, College of Computer and Information Sciences, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.ORCID 0000-0001-5957-1383
Mona M JamjoomDepartment of Computer Sciences, College of Computer and Information Sciences, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
Minia University · EGPrincess Nourah bint Abdulrahman University · SA

Funding

Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2023R104), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. PNURSP2023R104
6 · The paper itself

Abstract

It is crucial to accurately categorize cancers using microarray data. Researchers have employed a variety of computational intelligence approaches to analyze gene expression data. It is believed that the most difficult part of the problem of cancer diagnosis is determining which genes are informative. Therefore, selecting genes to study as a starting point for cancer classification is common practice. We offer a novel approach that combines the Runge Kutta optimizer (RUN) with a support vector machine (SVM) as the classifier to select the significant genes in the detection of cancer tissues. As a means of dealing with the high dimensionality that characterizes microarray datasets, the preprocessing stage of the ReliefF method is implemented. The proposed RUN-SVM approach is tested on binary-class microarray datasets (Breast2 and Prostate) and multi-class microarray datasets in order to assess its efficacy (i.e., Brain Tumor1, Brain Tumor2, Breast3, and Lung Cancer). Based on the experimental results obtained from analyzing six different cancer gene expression datasets, the proposed RUN-SVM approach was found to statistically beat the other competing algorithms due to its innovative search technique.

Indexed as

cancer classificationfeature selectiongene expressionmicroarrayRunge Kutta optimizersupport vector machines

Identifiers

PMID37175012
PMCPMC10178557
OpenAlexW4368367388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.